Isracann Biosciences (ISCNF) News Today Add Compare Share Share Headlines Stock AnalysisChart All Sources Trusted Sources MarketBeat Benzinga Bloomberg GuruFocus MarketWatch Motley Fool NASDAQ PR Newswire Reuters Seeking Alpha TalkMarkets The Street TipRanks The Wall Street Journal Wall Street Zen Yahoo Finance Source Sentiment refers to the positivity or negativity of each headline according to our language processing algorithm. Sentiment All Sentiments Very Positive Positive Neutral Negative Very Negative Most Recent February 2025 January 2025 December 2024 November 2024 October 2024 September 2024 August 2024 July 2024 June 2024 May 2024 April 2024 March 2024 February 2024 January 2024 December 2023 November 2023 October 2023 September 2023 August 2023 July 2023 June 2023 May 2023 April 2023 March 2023 February 2023 January 2023 December 2022 November 2022 October 2022 September 2022 August 2022 July 2022 June 2022 May 2022 April 2022 March 2022 Time Period Seattle biotech launches with technology co-invented by UW Nobel Prize winnerOctober 31, 2024 | bizjournals.comArchon emerges from stealth with $20M and ‘antibody cages’ to power up drug developmentOctober 30, 2024 | msn.comElevai Biosciences engages KCRN Research to support IND efforts for EL-22October 22, 2024 | markets.businessinsider.comMBX Biosciences IncSeptember 21, 2024 | morningstar.comIIROC Trading Halt - IPOTApril 6, 2023 | finance.yahoo.comIsracann Biosciences Inc. (ISCNF)April 6, 2023 | finance.yahoo.comISCNF Isracann Biosciences Inc.October 25, 2022 | seekingalpha.comIsracann Biosciences Provides Bi-Weekly Default Status ReportOctober 13, 2022 | finance.yahoo.comIsracann Bioscience Facilitated Genetics Arrive in IsraelSeptember 28, 2022 | finance.yahoo.comIsracann Bioscience Facilitates Cannabis Genetics Shipment To IsraelSeptember 14, 2022 | benzinga.comIsracann's Praesidio Expands Its Natural Health Products Distribution Network: Inks Deal With Pure Integrative PharmacySeptember 1, 2022 | msn.comPraesidio signs distribution agreement with Pure Integrative PharmacySeptember 1, 2022 | financialpost.comIsracann Biosciences adds Super Bowl MVP Mark Rypien to company advisory boardAugust 25, 2022 | proactiveinvestors.comIsracann Adds Super Bowl MVP and Mental Health Advocate Mark Rypien to Advisory BoardAugust 23, 2022 | finance.yahoo.comCannabis Company Isracann Biosciences Raises $234K In The First Tranche Of Private PlacementAugust 3, 2022 | msn.comIsracann Biosciences Announces Closing of First Tranche of $0.05 Unit Private PlacementAugust 3, 2022 | finance.yahoo.comIsracann Biosciences' Subsidiary Praesidio Health Submits NPNs To Health CanadaMay 21, 2022 | msn.comIsracann Biosciences Subsidiary Praesidio Health Submits NPNs to Health CanadaMay 19, 2022 | finance.yahoo.comIsracann Biosciences Renews Leadership to Meet Changing DemandsApril 15, 2022 | financialpost.comIsracann Biosciences acquires Praesidio Health and appoints products officersApril 14, 2022 | seekingalpha.comIsracann Biosciences Acquires Praesidio Health And Appoints Natural Health Products OfficersApril 14, 2022 | msn.comIsracann Biosciences Acquires Natural Health Medicine Developer and Appoints Natural Health Products OfficersApril 13, 2022 | finance.yahoo.comIsracann Biosciences Signs Definitive Agreement To Acquire Praesidio Health For $3.18MMarch 28, 2022 | msn.comIsracann Biosciences to acquire Canadian natural health medicine developerMarch 28, 2022 | seekingalpha.comIsracann Biosciences Signs Definitive Agreement to Acquire Natural Health Medicine DeveloperMarch 28, 2022 | finance.yahoo.comUPDATE - Isracann Signs LOI to Acquire Natural Health Medicine DeveloperFebruary 24, 2022 | finance.yahoo.comIsracann to acquire natural health medicine developerFebruary 23, 2022 | seekingalpha.comIsracann To Acquire Natural Health Medicine Developer Praesidio Health For $3.14MFebruary 23, 2022 | msn.comIsracann Signs LOI to Acquire Natural Health Medicine DeveloperFebruary 23, 2022 | financialpost.comIsracann Advises on Recent Activities and 2022 OutlookFebruary 9, 2022 | finance.yahoo.comIsracann Appoints Operational Expert Phil Floucault as CEO and Grants OptionsOctober 20, 2021 | finance.yahoo.comIsracann Appoints Experienced Farm Manager and Updates Israeli Cannabis OperationsAugust 31, 2021 | financialpost.com Get Isracann Biosciences News Delivered to You Automatically Sign up to receive the latest news and ratings for ISCNF and its competitors with MarketBeat's FREE daily newsletter. Email Address ISCNF Media Mentions By Week ISCNF Media Sentiment Learn about the media sentiment score. Each headline receives a score ranging from 2 (good news) to -2 (bad news). Our company news sentiment scores track the average news sentiment of articles about each company over the most recent 7 days in order to identify companies that are receiving positive press. ISCNF News Sentiment▼0.000.61▲Average Medical News Sentiment ISCNF News Coverage Learn about the media coverage comparison. We track news headlines from hundreds of news outlets and tag them by company. This chart compares the number of articles about this company in the last seven days compared with the average number of articles about this company on a typical week. ISCNF Articles This Week▼00▲ISCNF Articles Average Week Get Isracann Biosciences News Delivered to You Automatically Sign up to receive the latest news and ratings for ISCNF and its competitors with MarketBeat's FREE daily newsletter. Email Address Related Companies and Tools Related Companies 1933 Industries News 4Front Ventures News AB Science News Acreage News Almirall News Amazonas Florestal News American Green News Avant Brands News Avicanna News BioSyent News Headlines Tools Trending Media MentionsHigh Media Sentiment StocksLive News FeedMarketBeat OriginalsStock Ideas This page (OTCMKTS:ISCNF) was last updated on 2/23/2025 by MarketBeat.com Staff From Our PartnersCollect $7k per month from Tesla’s SECRET dividendTesla doesn't pay a traditional dividend.... But I just discovered a secret backdoor to collect a secret 69...Investors Alley | SponsoredHas Trump finally met his match?Dylan Jovine predicted the 2008 crash over a year before it happened. Folks who listened to him had the chance...Behind the Markets | SponsoredElon “obliterates” Bill Gates?All 10 of the world's biggest money managers follow my work, and the Pentagon, the FBI and Harvard professors ...Altimetry | Sponsored$2 Trillion Disappears Because of Fed's Secretive New Move$2 trillion has disappeared from the US government's books. The reason why is a new, secretive move being c...Stansberry Research | SponsoredNVDA Crash UpdateAn overseas AI rival sent shockwaves through the U.S. tech market last week... Leaving millions of investor...Chaikin Analytics | SponsoredBetter than Bitcoin – and potentially more profitableThe world is obsessed with Bitcoin again... And for a good reason: It just soared beyond $100,000. Bitcoin ...Brownstone Research | SponsoredNvidia > DeepSeekEveryone's getting it all wrong … Sure, DeepSeek's reveal caused AI stocks to tumble … But, in the long ...Weiss Ratings | SponsoredSecret financial plot unfolding in Washington DC… [DEVELOPING]What stocks are next up to soar in 2025? I believe I’ve found the answer - and it might surprise you. Yo...Timothy Sykes | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Isracann Biosciences Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Share Isracann Biosciences With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
